• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 CAR-T 细胞大小的激活。

Size-dependent activation of CAR-T cells.

机构信息

Department of Cell Biology, Yale School of Medicine, New Haven, CT 06520, USA.

Duncan and Nancy MacMillan Cancer Immunology and Metabolism Center of Excellence, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ 08903, USA.

出版信息

Sci Immunol. 2022 Aug 5;7(74):eabl3995. doi: 10.1126/sciimmunol.abl3995.

DOI:10.1126/sciimmunol.abl3995
PMID:35930653
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9678385/
Abstract

As the targets of chimeric antigen receptor (CAR)-T cells expand to a variety of cancers, autoimmune diseases, viral infections, and fibrosis, there is an increasing demand for identifying new antigens and designing new CARs that can be effectively activated. However, the rational selection of antigens and the design of CARs are limited by a lack of knowledge regarding the molecular mechanism by which CARs are activated by antigens. Here, we present data supporting a "size exclusion" model explaining how antigen signals are transmitted across the plasma membrane to activate the intracellular domains of CARs. In this model, antigen engagement with CAR results in a narrow intermembrane space that physically excludes CD45, a bulky phosphatase, out of the CAR zone, thus favoring CAR phosphorylation by kinases, which further triggers downstream pathways leading to T cell activation. Aligned with this model, increasing the size of CAR extracellular domains diminished CAR-T activation both in vitro and in a mouse lymphoma model; membrane-proximal epitopes activated CAR-Ts better than membrane-distal epitopes. Moreover, increasing the size of CD45 by antibody conjugation enhanced the activation of CARs that recognize membrane-distal epitopes. Consistently, CAR-Ts expressing CD45RABC, the larger isoform, were activated to a higher level than those expressing a smaller isoform CD45RO. Together, our work revealed that CAR-T activation depends on the size difference between the CAR-antigen pair and CD45; the size of CAR, antigen, and CD45 can thus be targets for tuning CAR-T activation.

摘要

随着嵌合抗原受体 (CAR)-T 细胞的靶点扩展到多种癌症、自身免疫性疾病、病毒感染和纤维化,人们对识别新抗原和设计新的能够有效激活的 CAR 的需求日益增加。然而,由于缺乏关于 CAR 通过抗原激活的分子机制的知识,抗原和 CAR 的合理选择受到限制。在这里,我们提供的数据支持一种“尺寸排除”模型,该模型解释了抗原信号如何穿过质膜传递以激活 CAR 的细胞内结构域。在该模型中,CAR 与抗原的结合导致质膜之间的空间变窄,从而将体积庞大的磷酸酶 CD45 排除在 CAR 区域之外,从而有利于激酶对 CAR 的磷酸化,这进一步触发下游途径导致 T 细胞激活。与该模型一致的是,增加 CAR 细胞外结构域的大小会在体外和小鼠淋巴瘤模型中均降低 CAR-T 的激活;靠近膜的表位比远离膜的表位更好地激活 CAR-T。此外,通过抗体缀合增加 CD45 的大小增强了对识别远离膜的表位的 CAR 的激活。一致地,表达更大的 CD45RABC 同工型的 CAR-T 比表达更小的 CD45RO 同工型的 CAR-T 被激活到更高的水平。总之,我们的工作揭示了 CAR-T 激活取决于 CAR-抗原对和 CD45 之间的大小差异;因此,CAR、抗原和 CD45 的大小可以成为调节 CAR-T 激活的目标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f37b/9678385/2a1317f8c592/nihms-1847636-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f37b/9678385/2e89bb58fc32/nihms-1847636-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f37b/9678385/02b820844ff3/nihms-1847636-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f37b/9678385/f122e91bb9d0/nihms-1847636-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f37b/9678385/b9a8253055e5/nihms-1847636-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f37b/9678385/296b897522df/nihms-1847636-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f37b/9678385/4655a77bbff1/nihms-1847636-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f37b/9678385/2a1317f8c592/nihms-1847636-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f37b/9678385/2e89bb58fc32/nihms-1847636-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f37b/9678385/02b820844ff3/nihms-1847636-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f37b/9678385/f122e91bb9d0/nihms-1847636-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f37b/9678385/b9a8253055e5/nihms-1847636-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f37b/9678385/296b897522df/nihms-1847636-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f37b/9678385/4655a77bbff1/nihms-1847636-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f37b/9678385/2a1317f8c592/nihms-1847636-f0007.jpg

相似文献

1
Size-dependent activation of CAR-T cells.基于 CAR-T 细胞大小的激活。
Sci Immunol. 2022 Aug 5;7(74):eabl3995. doi: 10.1126/sciimmunol.abl3995.
2
A Novel Siglec-4 Derived Spacer Improves the Functionality of CAR T Cells Against Membrane-Proximal Epitopes.一种新型 Siglec-4 衍生间隔物可改善 CAR T 细胞针对膜近端表位的功能。
Front Immunol. 2020 Aug 7;11:1704. doi: 10.3389/fimmu.2020.01704. eCollection 2020.
3
Development of CAR T Cells Expressing a Suicide Gene Plus a Chimeric Antigen Receptor Targeting Signaling Lymphocytic-Activation Molecule F7.表达自杀基因和靶向信号淋巴细胞激活分子 F7 的嵌合抗原受体的 CAR T 细胞的开发。
Mol Ther. 2021 Feb 3;29(2):702-717. doi: 10.1016/j.ymthe.2020.10.008. Epub 2020 Oct 14.
4
Imaging CAR-T Synapse as a Quality Control for CAR Engineering.将 CAR-T 突触成像作为 CAR 工程的质量控制。
Methods Mol Biol. 2023;2654:503-512. doi: 10.1007/978-1-0716-3135-5_33.
5
Fully human antibody V domains to generate mono and bispecific CAR to target solid tumors.生成针对实体瘤的单特异性和双特异性 CAR 的全人源抗体 V 结构域。
J Immunother Cancer. 2021 Apr;9(4). doi: 10.1136/jitc-2020-002173.
6
Scrutiny of chimeric antigen receptor activation by the extracellular domain: experience with single domain antibodies targeting multiple myeloma cells highlights the need for case-by-case optimization.对嵌合抗原受体胞外结构域激活的研究:靶向多发性骨髓瘤细胞的单域抗体的经验突出了需要针对具体情况进行优化。
Front Immunol. 2024 Apr 19;15:1389018. doi: 10.3389/fimmu.2024.1389018. eCollection 2024.
7
Programmable Attenuation of Antigenic Sensitivity for a Nanobody-Based EGFR Chimeric Antigen Receptor Through Hinge Domain Truncation.通过铰链域截断实现基于纳米抗体的 EGFR 嵌合抗原受体的抗原敏感性可编程衰减。
Front Immunol. 2022 Jul 22;13:864868. doi: 10.3389/fimmu.2022.864868. eCollection 2022.
8
Imaging Chimeric Antigen Receptor (CAR) Activation.影像嵌合抗原受体 (CAR) 激活。
Methods Mol Biol. 2020;2111:153-160. doi: 10.1007/978-1-0716-0266-9_13.
9
Inefficient CAR-proximal signaling blunts antigen sensitivity.CAR 近端信号转导效率低下会削弱抗原敏感性。
Nat Immunol. 2020 Aug;21(8):848-856. doi: 10.1038/s41590-020-0719-0. Epub 2020 Jul 6.
10
Inclusion of 4-1BB Costimulation Enhances Selectivity and Functionality of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells.4-1BB 共刺激的加入增强了靶向 IL13Rα2 的嵌合抗原受体 T 细胞的选择性和功能。
Cancer Res Commun. 2023 Jan 17;3(1):66-79. doi: 10.1158/2767-9764.CRC-22-0185. eCollection 2023 Jan.

引用本文的文献

1
Conversion of natural cytokine receptors into orthogonal synthetic biosensors.将天然细胞因子受体转化为正交合成生物传感器。
Nat Chem Biol. 2025 Aug 22. doi: 10.1038/s41589-025-01986-1.
2
Immunological synapse: structures, molecular mechanisms and therapeutic implications in disease.免疫突触:结构、分子机制及在疾病中的治疗意义
Signal Transduct Target Ther. 2025 Aug 11;10(1):254. doi: 10.1038/s41392-025-02332-6.
3
CD45 sequestration lowers the signaling threshold in lymphocytes and enhances anti-tumor immunity.CD45隔离降低淋巴细胞中的信号阈值并增强抗肿瘤免疫力。

本文引用的文献

1
Roadmap to affinity-tuned antibodies for enhanced chimeric antigen receptor T cell function and selectivity.亲和力优化抗体增强嵌合抗原受体T细胞功能和选择性的路线图
Trends Biotechnol. 2022 Jul;40(7):875-890. doi: 10.1016/j.tibtech.2021.12.009. Epub 2022 Jan 22.
2
Height, but not binding epitope, affects the potency of synthetic TCR agonists.高度而非结合表位会影响合成TCR激动剂的效力。
Biophys J. 2021 Nov 16;120(22):5136-5137. doi: 10.1016/j.bpj.2021.10.022. Epub 2021 Nov 6.
3
Characterization of mechanisms positioning costimulatory complexes in immune synapses.
bioRxiv. 2025 Aug 1:2025.07.29.667400. doi: 10.1101/2025.07.29.667400.
4
T cell protrusions enable fast, localised initiation of CAR signalling.T细胞突起可实现CAR信号的快速、局部启动。
bioRxiv. 2025 Jul 9:2025.07.08.662959. doi: 10.1101/2025.07.08.662959.
5
Nanomaterial assisted natural killer cell therapy.纳米材料辅助自然杀伤细胞疗法。
Front Immunol. 2025 May 5;16:1558701. doi: 10.3389/fimmu.2025.1558701. eCollection 2025.
6
Recent advances in biomimetic nanodelivery systems for cancer Immunotherapy.用于癌症免疫治疗的仿生纳米递送系统的最新进展。
Mater Today Bio. 2025 Apr 5;32:101726. doi: 10.1016/j.mtbio.2025.101726. eCollection 2025 Jun.
7
Preclinical development of anti-CD21 chimeric antigen receptor T cells to treat T cell acute lymphoblastic leukemia.用于治疗T细胞急性淋巴细胞白血病的抗CD21嵌合抗原受体T细胞的临床前开发。
Sci Transl Med. 2025 Apr 16;17(794):eadr1476. doi: 10.1126/scitranslmed.adr1476.
8
Expanding the CAR toolbox with high throughput screening strategies for CAR domain exploration: a comprehensive review.通过高通量筛选策略扩展用于CAR结构域探索的CAR工具库:全面综述
J Immunother Cancer. 2025 Apr 9;13(4):e010658. doi: 10.1136/jitc-2024-010658.
9
Design of sensitive monospecific and bispecific synthetic chimeric T cell receptors for cancer therapy.用于癌症治疗的灵敏单特异性和双特异性合成嵌合T细胞受体的设计。
Nat Cancer. 2025 Apr;6(4):647-665. doi: 10.1038/s43018-025-00927-0. Epub 2025 Mar 17.
10
Post-translational modifications in hepatocellular carcinoma: unlocking new frontiers in immunotherapy.肝细胞癌中的翻译后修饰:开启免疫治疗的新前沿
Front Immunol. 2025 Feb 18;16:1554372. doi: 10.3389/fimmu.2025.1554372. eCollection 2025.
免疫突触中协同刺激复合物定位机制的表征
iScience. 2021 Sep 9;24(10):103100. doi: 10.1016/j.isci.2021.103100. eCollection 2021 Oct 22.
4
Structural details of monoclonal antibody m971 recognition of the membrane-proximal domain of CD22.单克隆抗体 m971 识别 CD22 膜近端结构域的结构细节。
J Biol Chem. 2021 Aug;297(2):100966. doi: 10.1016/j.jbc.2021.100966. Epub 2021 Jul 14.
5
Highly accurate protein structure prediction with AlphaFold.利用 AlphaFold 进行高精度蛋白质结构预测。
Nature. 2021 Aug;596(7873):583-589. doi: 10.1038/s41586-021-03819-2. Epub 2021 Jul 15.
6
The CAR T-Cell Mechanoimmunology at a Glance.嵌合抗原受体T细胞力学免疫学概述
Adv Sci (Weinh). 2020 Nov 3;7(24):2002628. doi: 10.1002/advs.202002628. eCollection 2020 Dec.
7
Enhanced CAR-T activity against established tumors by polarizing human T cells to secrete interleukin-9.通过极化人 T 细胞分泌白细胞介素-9增强对已建立肿瘤的 CAR-T 活性。
Nat Commun. 2020 Nov 19;11(1):5902. doi: 10.1038/s41467-020-19672-2.
8
Cell-cell interfaces as specialized compartments directing cell function.细胞-细胞界面作为专门的隔室指导细胞功能。
Nat Rev Mol Cell Biol. 2020 Dec;21(12):750-764. doi: 10.1038/s41580-020-00298-7. Epub 2020 Oct 22.
9
Multiple Signaling Roles of CD3ε and Its Application in CAR-T Cell Therapy.CD3ε 的多重信号作用及其在 CAR-T 细胞治疗中的应用。
Cell. 2020 Aug 20;182(4):855-871.e23. doi: 10.1016/j.cell.2020.07.018. Epub 2020 Jul 29.
10
Rewired signaling network in T cells expressing the chimeric antigen receptor (CAR).表达嵌合抗原受体 (CAR) 的 T 细胞中的重排信号网络。
EMBO J. 2020 Aug 17;39(16):e104730. doi: 10.15252/embj.2020104730. Epub 2020 Jul 9.